Favaron A - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Characterising and preventing the gut microbiota's inactivation of trifluridine, a colorectal cancer drug.

McCoubrey LE, Shen C, Mwasambu S, Favaron A, Sangfuang N, Thomaidou S, Orlu M, Globisch D, Basit AW. McCoubrey LE, et al. Among authors: favaron a. Eur J Pharm Sci. 2024 Dec 1;203:106922. doi: 10.1016/j.ejps.2024.106922. Epub 2024 Oct 3. Eur J Pharm Sci. 2024. PMID: 39368784 Free article.

Exploring the interactions of JAK inhibitor and S1P receptor modulator drugs with the human gut microbiome: Implications for colonic drug delivery and inflammatory bowel disease.

Favaron A, Abdalla Y, McCoubrey LE, Nandiraju LP, Shorthouse D, Gaisford S, Basit AW, Orlu M. Favaron A, et al. Eur J Pharm Sci. 2024 Sep 1;200:106845. doi: 10.1016/j.ejps.2024.106845. Epub 2024 Jul 5. Eur J Pharm Sci. 2024. PMID: 38971433 Free article.

Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinib.

Favaron A, Hens B, Camotti Montanha M, McAllister M, Tomaszewska I, Moustafa S, de Oliveira MA, Basit AW, Orlu M. Favaron A, et al. J Control Release. 2024 Jun;370:182-194. doi: 10.1016/j.jconrel.2024.04.024. Epub 2024 Apr 25. J Control Release. 2024. PMID: 38641022 Free article.

Do probiotic interventions improve female unexplained infertility? A critical commentary.

Favaron A, Turkgeldi E, Elbadawi M, Gaisford S, Basit AW, Orlu M. Favaron A, et al. Reprod Biomed Online. 2024 Apr;48(4):103734. doi: 10.1016/j.rbmo.2023.103734. Epub 2023 Nov 20. Reprod Biomed Online. 2024. PMID: 38359733

Colonic drug delivery: Formulating the next generation of colon-targeted therapeutics.

McCoubrey LE, Favaron A, Awad A, Orlu M, Gaisford S, Basit AW. McCoubrey LE, et al. Among authors: favaron a. J Control Release. 2023 Jan;353:1107-1126. doi: 10.1016/j.jconrel.2022.12.029. Epub 2022 Dec 24. J Control Release. 2023. PMID: 36528195 Free article. Review.

N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria.

Laws M, Hind C, Favaron A, Jamshidi S, Evans B, Clifford M, Sutton JM, Rahman KM. Laws M, et al. Among authors: favaron a. ACS Omega. 2020 May 18;5(21):11923-11934. doi: 10.1021/acsomega.9b03910. eCollection 2020 Jun 2. ACS Omega. 2020. PMID: 32548371 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6 results

Search Page

Filters